HighTower Advisors, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$256,000
-29.7%
4,242
-14.9%
0.00%0.0%
Q4 2022$364,000
-17.5%
4,985
-13.9%
0.00%0.0%
Q3 2022$441,000
-0.7%
5,787
-9.4%
0.00%0.0%
Q2 2022$444,000
-25.0%
6,389
-10.3%
0.00%0.0%
Q1 2022$592,000
+4.8%
7,120
-5.0%
0.00%0.0%
Q4 2021$565,000
-35.8%
7,494
-0.9%
0.00%
-50.0%
Q3 2021$880,000
-44.8%
7,562
+3.8%
0.00%
-60.0%
Q2 2021$1,594,000
+40.1%
7,283
-15.4%
0.01%
+25.0%
Q1 2021$1,138,000
-18.0%
8,611
+7.7%
0.00%
-33.3%
Q4 2020$1,387,000
+59.4%
7,993
-2.8%
0.01%
+50.0%
Q3 2020$870,000
+64.5%
8,227
-8.7%
0.00%
+33.3%
Q2 2020$529,000
-12.7%
9,008
-7.1%
0.00%
-25.0%
Q1 2020$606,000
-16.3%
9,693
+12.9%
0.00%0.0%
Q4 2019$724,000
+8.1%
8,584
-4.2%
0.00%0.0%
Q3 2019$670,000
-3.3%
8,965
-18.1%
0.00%0.0%
Q2 2019$693,000
+165.5%
10,950
+102.0%
0.00%
+100.0%
Q1 2019$261,000
-0.8%
5,420
-31.7%
0.00%0.0%
Q4 2018$263,000
-72.0%
7,935
-56.0%
0.00%
-71.4%
Q3 2018$939,000
+61.9%
18,032
-3.3%
0.01%
+40.0%
Q2 2018$580,000
+60.7%
18,643
+6.9%
0.01%
+66.7%
Q1 2018$361,00017,4430.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders